Does Trump Benefit Financially by Promoting Hydroxychloroquine as COVID-19 Treatment?

U.S. President Donald Trump’s enthusiastic promotion of the anti-malarial drug hydroxychloroquine as a treatment for COVID-19, despite a lack of controlled trials or non-anecdotal evidence for its efficacy, has led some to speculate that he has a financial interest in the drug. The notion gained significant traction when The New York Times reported that Trump … Continue reading Does Trump Benefit Financially by Promoting Hydroxychloroquine as COVID-19 Treatment?